• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Melanoma antigen preferentially expressed in tumors (PRAME)

To achieve the expression of the recombinant Human PRAME protein in Yeast cells, a DNA fragment encoding the Human PRAME protein (1-509aa) is inserted into a plasmid vector, which is then transferred to Yeast cells. After screening positive cells, they are cultured and induced to generate the PRAME protein. A N-terminal 6xHis tag is attached to the protein. Cells are lysed to collect the recombinant Human PRAME protein, which is purified through affinity purification and then identified using SDS-PAGE and subsequent staining of the gel with Coomassie Brilliant Blue. The purity of the obtained recombinant Human PRAME protein is over 90%.

ACP03918

To achieve the expression of the recombinant Human PRAME protein in Yeast cells, a DNA fragment encoding the Human PRAME protein (1-509aa) is inserted into a plasmid vector, which is then transferred to Yeast cells. After screening positive cells, they are cultured and induced to generate the PRAME protein. A N-terminal 6xHis tag is attached to the protein. Cells are lysed to collect the recombinant Human PRAME protein, which is purified through affinity purification and then identified using SDS-PAGE and subsequent staining of the gel with Coomassie Brilliant Blue. The purity of the obtained recombinant Human PRAME protein is over 90%.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP03918 Target NamePRAME
FormLiquid or Lyophilized powderExpression SystemYeast
Expression Range1-509aaMol Weight59.9kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP78395
Background Information
  • Uniprot Id

    P78395

  • Target Species

    Human

  • Target Name

    PRAME

  • Target Full Name

    Melanoma antigen preferentially expressed in tumors

  • Target Function

    Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex, which mediates ubiquitination of target proteins, leading to their degradation. The CRL2(PRAME) complex mediates ubiquitination and degradation of truncated MSRB1/SEPX1 selenoproteins produced by failed UGA/Sec decoding. In the nucleus, the CRL2(PRAME) complex is recruited to epigenetically and transcriptionally active promoter regions bound by nuclear transcription factor Y (NFY) and probably plays a role in chromstin regulation. Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG: prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.

  • Target Subcellular Location

    Nucleus. Chromosome. Cytoplasm. Golgi apparatus. Cell membrane.

  • Target Protein Families

    PRAME family

  • Target Tissue Specificity

    Expressed in testis. Detected in samples of kidney, brain and skin.

  • Target Research Area

    Apoptosis

  • Target Synonyms

    4930534P07Rik; Cancer/testis antigen 130; CT130; MAPE; Melanoma antigen preferentially expressed in tumors; OIP 4; OIP-4; OIP4 ; OPA interacting protein 4; Opa interacting protein OIP4; OPA-interacting protein 4; PRAME; PRAME_HUMAN; Preferentially expressed antigen in melanoma ; Preferentially expressed antigen of melanoma; RP23-250F8.3

  • Target Background

    This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human Melanoma antigen preferentially expressed in tumors (PRAME) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification